Non-small-cell lung cancer

C Gridelli, A Rossi, DP Carbone, J Guarize… - Nature reviews Disease …, 2015 - nature.com
Lung cancer is one of the most frequently diagnosed cancers and is the leading cause of
cancer-related death worldwide. Non-small-cell lung cancer (NSCLC), a heterogeneous …

Map** of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050

R Sharma - International Journal of Clinical Oncology, 2022 - Springer
Aim Lung cancer is the leading cause of cancer deaths worldwide. This study examines the
current and future burden of lung cancer at global, regional, and national levels. Methods …

Chronic obstructive pulmonary disease (COPD) and lung cancer screening

RP Young, RJ Hopkins - Translational lung cancer research, 2018 - pmc.ncbi.nlm.nih.gov
The primary aim of lung cancer screening is to improve survival from lung cancer by
identifying early stage non-small cell lung cancers and prolong survival through their …

Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial–American College of Radiology …

RJ Hopkins, F Duan, C Chiles, EM Greco… - Annals of the …, 2017 - atsjournals.org
Rationale: Although epidemiological studies consistently show that chronic obstructive
pulmonary disease is associated with an increased risk of lung cancer, debate exists as to …

Overdiagnosis in lung cancer screening: why modelling is essential

K Ten Haaf, HJ de Koning - J Epidemiol Community Health, 2015 - jech.bmj.com
Screening for diseases is an important part of healthcare, as the detection of disease at an
early stage may improve the chance of successful treatment of the disease. Although high …

Chronic obstructive pulmonary disease and lung cancer: inter-relationships

A Biswas, HJ Mehta, EE Folch - Current opinion in pulmonary …, 2018 - journals.lww.com
Current Opinion in Pulmonary Medicine Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Características al diagnóstico y supervivencia de estadios iy ii de cáncer de pulmón

O Pérez-Martínez, I Vidal-García… - Archivos de …, 2018 - Elsevier
Introducción El objetivo de nuestro estudio es detallar las características de los pacientes
diagnosticados en estadios iy ii de cáncer de pulmón en el área sanitaria de A Coruña …

Highly sensitive marker panel for guidance in lung cancer rapid diagnostic units

S Blanco-Prieto, L De Chiara, M Rodríguez-Girondo… - Scientific Reports, 2017 - nature.com
While evidence for lung cancer screening implementation in Europe is awaited, Rapid
Diagnostic Units have been established in many hospitals to accelerate the early diagnosis …

Measures of outcome in lung cancer screening: maximising the benefits

RP Young, RJ Hopkins - Journal of Thoracic Disease, 2016 - pmc.ncbi.nlm.nih.gov
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2016; 8 (10): E1317-E1320
jtd. amegroups. com a post-hoc analysis of the NLST where a favourable stage shift in the …

Description and survival of stage I and II lung cancer patients

O Pérez-Martínez, I Vidal-García… - Archivos de …, 2018 - Elsevier
Introduction The objective of our study was to describe the characteristics of patients
diagnosed with stage I and II lung cancer in the health area of A Coruña (Galicia) and to …